van den Burg, Elske L. http://orcid.org/0000-0002-3149-5304
Schoonakker, Marjolein P. http://orcid.org/0000-0003-1014-4190
van Peet, Petra G. http://orcid.org/0000-0002-7963-6575
van den Akker-van Marle, Elske M. http://orcid.org/0000-0002-5269-509X
Lamb, Hildo J. http://orcid.org/0000-0002-6969-2418
Longo, Valter D. http://orcid.org/0000-0002-0946-7534
Numans, Mattijs E. http://orcid.org/0000-0002-0368-5426
Pijl, Hanno http://orcid.org/0000-0002-3076-1551
Funding for this research was provided by:
L-Nutra
Diabetes Fonds
Health~Holland
Article History
Received: 11 October 2023
Accepted: 22 February 2024
First Online: 28 March 2024
Acknowledgements
: We gratefully acknowledge the contribution of all participants, the trial steering committee, the general practice centres, supporting staff and research nurses involved in the trial.
: The datasets generated during and/or analysed in the current study are available upon reasonable request. Requests should be sent to the Fasting In diabetes Treatment (FIT) trial correspondence email (fit@lumc.nl). All proposals requesting data access will need to specify how the data will be used, and all proposals will require the approval of the trial co-investigator team before data release.
: The project was co-funded by Health~Holland, Top Sector Life Sciences & Health and the Dutch Diabetes Foundation. L-Nutra contributed the formula diet and a small part of the funding. External peer review took place during the funding process and was performed by ZonMw (the Netherlands Organisation for Health Research and Development). The funders of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, approval of the manuscript or the decision to submit the manuscript for publication.
: The authors declare that financial support for the project was received from Health~Holland, Top Sector Life Sciences & Health, the Dutch Diabetes Foundation and L-Nutra. VDL is a founder and shareholder of L-Nutra (his shares are assigned to the Create Cures Foundation and other charitable and research organisations), owns patents licensed to L-Nutra, receives support for travel expenses from L-Nutra and is on the advisory board of L-Nutra. HJL has received consulting fees from Royal Philips and was a member of the board of trustees of the Society for Cardiovascular Magnetic Resonance and European Union of Medical Specialists Radiology section without payment. The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: ELvdB and MPS contributed equally to this paper. All authors contributed to the study design. ELvdB and MPS conducted the trial, accessed and verified the data, and performed the data analysis. ELvdB, MPS, PGvP and HP prepared the first draft of the manuscript. All authors participated in data interpretation, critical review and revision of the manuscript, and had final responsibility for the decision to submit for publication. HP is the guarantor of this work, and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.